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Abstract. 
 
Is membrane fusion an essentially passive or 
an active process? It could be that fusion proteins sim-
ply need to pin two bilayers together long enough, and 
the bilayers could do the rest spontaneously. Or, it 
could be that the fusion proteins play an active role af-
ter pinning two bilayers, exerting force in the bilayer in 
one or another way to direct the fusion process. To dis-
tinguish these alternatives, we replaced one or both of 
the peptidic membrane anchors of exocytic vesicle (v)- 
and target membrane (t)-SNAREs (soluble N-ethylma-
leimide-sensitive fusion protein [NSF] attachment pro-
tein [SNAP] receptor) with covalently attached lipids. 
Replacing either anchor with a phospholipid prevented 
fusion of liposomes by the isolated SNAREs, but still 
allowed assembly of trans-SNARE complexes docking 
vesicles. This result implies an active mechanism; if fu-
sion occurred passively, simply holding the bilayers to-
gether long enough would have been sufﬁcient. Studies 
using polyisoprenoid anchors ranging from 15–55 car-
bons and multiple phospholipid-containing anchors
reveal distinct requirements for anchors of v- and
t-SNAREs to function: v-SNAREs require anchors ca-
pable of spanning both leaﬂets, whereas t-SNAREs do 
not, so long as the anchor is sufﬁciently hydrophobic. 
These data, together with previous results showing fu-
sion is inhibited as the length of the linker connecting 
the helical bundle-containing rod of the SNARE com-
plex to the anchors is increased (McNew, J.A., T. Weber, 
D.M. Engelman, T.H. Sollner, and J.E. Rothman. 1999. 
 
Mol. Cell
 
. 4:415–421), suggests a model in which one ac-
tivity of the SNARE complex promoting fusion is to ex-
ert force on the anchors by pulling on the linkers. This 
motion would lead to the simultaneous inward move-
ment of lipids from both bilayers, and in the case of the 
v-SNARE, from both leaﬂets.
Key words: lipid mixing • isoprene • liposome • lipid 
anchor • vesicular transport
 
Introduction
 
Membrane fusion, in which two distinct lipid bilayer mem-
branes are merged into one, is the common final step in
the transport of proteins among intracellular compart-
ments, the controlled release of hormones and neurotrans-
mitters by exocytosis, and the penetration of the genomes
of enveloped viruses into the cytoplasm. Remarkably,
common physical principles appear to underlie these di-
verse biological processes that involve fusion on both sides
of cellular membranes.
Intracellular membrane fusion is triggered by the pair-
ing of cognate vesicle (v)
 
1
 
-SNAREs (soluble N-ethylmale-
imide-sensitive fusion protein [NSF] attachment protein
[SNAP] receptor) and target membrane (t)-SNAREs be-
tween opposite bilayers (Sollner et al., 1993; Nichols et al.,
1997; Weber et al., 1998; Chen and Whiteheart, 1999; Mc-
New et al., 1999; Nickel et al., 1999; Parlati et al., 1999).
These proteins assemble into a helical bundle (Poirier et al.,
1998; Sutton et al., 1998) in which the hydrophobic an-
chors of both v- and t-SNAREs emerge at the same end
(Hanson et al., 1997b; Hohl et al., 1998; Poirier et al., 1998;
Sutton et al., 1998). As a result, the involved bilayers are
held into close apposition by these SNAREpins (Weber
et al., 1998). Fusion from this structure occurs with high ef-
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ficiency and at a reasonable rate in the absence of any
other proteins, demonstrating that the SNAREpins them-
selves are the underlying principle of intracellular mem-
brane fusion (Weber et al., 1998). In fact, fusion requires
only the helical bundle portion of the SNARE complex
(Parlati et al., 1999).
Viral membrane fusion is mediated by extracellular vi-
ral-encoded proteins embedded in the viral envelope that
are activated by receptor binding at the cell surface or en-
docytosis (Dalgleish et al., 1984; Klatzmann et al., 1984;
Maddon et al., 1986; Feng et al., 1996). Upon activation,
they can undergo a dramatic conformational switch to
form a helical bundle; like the SNAREpin, this viral hair-
pin is simultaneously inserted into both membrane part-
ners (reviewed by Skehel and Wiley, 1998). Before activa-
tion, viral fusion proteins are anchored solely in the viral
envelope. Therefore, during this switch, the viral protein
must insert into the cellular membrane. This is typically
mediated by a specialized fusion peptide that is buried in
the protein structure before activation (Wilson et al., 1981).
These models raise the fundamental question of whether
membrane fusion is an essentially passive or an active pro-
cess. It could be that simply pinning two bilayers together
long enough is sufficient for fusion; the bilayers could do
the rest spontaneously. Or, it could be that the fusion pro-
teins play an active role after pinning, in one or another
way perturbing the lipids by exerting force in the bilayer.
The assembly of the helical bundles that comprise pins
would seem to afford an ample source of energy to do
work on the bilayer, since isolated SNARE complexes and
viral helical bundles only denature at temperatures above
80–90
 
8
 
C (Hayashi et al., 1994; Lu et al., 1995; Lamb et al.,
1999).
In principle, it is possible to distinguish an active from a
passive mechanism by examining the effect upon fusion
activity of replacing one or both of the peptidic membrane
anchors of fusogenic pins with covalently attached lipids.
If fusion occurs passively, it should not be adversely af-
fected by lipid anchors since simply holding the bilayers
together long enough is by definition sufficient. If, how-
ever, fusion is found not to occur with some or all species
of lipid anchors, then it necessarily involves an active
mechanism, since in at least some cases simply holding the
bilayers together long enough did not suffice. Of course,
for these conclusions to hold, the separation of the two bi-
layers must remain constant independent of the nature of
the anchor, or equivalently, fusion must be shown to be in-
sensitive to variations in separation in the range resulting
from substituting lipid anchors. Also, the assembly of the
pin must be unaffected by lipid substitution.
Elegant and pioneering studies have shown that replac-
ing the natural peptidic anchor that holds viral fusion pro-
teins into the envelope with an encodable phospholipid-
based glycerophosphoinositide (GPI) unit prevents fusion
and results in hemifusion, a state where outer leaflets
merge, but the inner leaflets do not (Kemble et al., 1994;
Melikyan et al., 1995). However, a recent study suggests
that GPI-linked HA can produce nonexpanding fusion pores
under certain experimental conditions (Markosyan et al.,
2000). These results establish the importance of the viral
membrane anchor and are consistent with the possibility
that fusion involves an active mechanism. However, it is
 
also possible that hemifusion and subsequent effects are a
unique consequence of a GPI-anchor and the viral fusion
peptide. Insertion of the fusion peptide may destabilize bi-
layer structure and possibly facilitate the bilayer-to-nonbi-
layer transition that is likely required for hemifusion. Un-
fortunately, it is not presently possible to lipid-anchor viral
fusion proteins in both the viral and target membrane to
eliminate viral fusion peptide-specific phenomena.
By contrast, SNARE proteins are well suited for such
studies because the two membrane anchors can be manip-
ulated in separate polypeptide chains and tested later
when reconstituted into liposomes. Here, we make pre-
cisely such changes in cognate SNAREs mediating exocy-
tosis, vesicle-associated membrane protein 2 (VAMP2, the
v-SNARE), a heterodimer of syntaxin1A, and a synap-
tosomal-associated protein of 25 kD (SNAP-25B, the
t-SNARE; Trimble et al., 1988; Baumert et al., 1989; Oyler
et al., 1989; Bennett et al., 1992; Sollner et al., 1993). We
find that close proximity of two membranes is not suffi-
cient for fusion, though there are certain lipid anchors that
appear to permit lipid mixing. Additionally, we describe
the synthesis and utilization of four novel isoprenoid lipid
anchors.
 
Materials and Methods
 
Chemicals
 
The isoprenyl alcohols used for lipid synthesis were obtained from
the following vendors. Undecaprenol, solanesol, and farnesol were
from Sigma-Aldrich and geranylgeraniol was from Metrya. N, N
 
9
 
-dicyclo-
hexyl-carbodiimide and N-maleoly-
 
b
 
-alanine were from Fluka, and
4–dimethylaminopyridine (DMAP) was from Sigma-Aldrich. All other
phospholipids and 1,2-dioleoyl-sn-glycero-phosphoethanolamine-N-[4-
(p-maleimidophenyl) butyramide] were from Avanti Polar Lipids as
chloroform solutions.
 
DNA Manipulations and Plasmid Constructs
 
All PCR was done with 
 
Pwo 
 
polymerase (BM), except QuickChange mu-
tagenesis, which was done with 
 
Pfu
 
 polymerase according to the manufac-
turer’s instructions (Stratagene). All other DNA modifying enzymes were
from New England Biolabs. The 
 
E. coli
 
 strains were DH5a (GIBCO
BRL) for standard cloning or XL1-Blue for QuickChange mutagenesis.
 
Generation of Constructs for Lipid Anchor Attachment
 
The cytoplasmic domain of syntaxin1A was generated by PCR using
pJM26 (McNew et al., 1999) as a template and the oligo NcoI–rSyn1A
(CGCCATGGCC ATGAAGGACC GAACCCAGG) and rSyn1A-Cys
(GGCTCGAGTT AGCAAAGCTT CTTCCTGCGT GCC). This NcoI–
XhoI fragment was ligated into pET28a (Novagen), cut with the same
enzymes. This plasmid (pJM52) codes for syntaxin1A without a trans-
membrane domain (TMD), but an ultimate cysteine residue. A naturally
occurring cysteine residue at amino acid 145 was removed from pJM52 by
site-directed mutagenesis using the QuickChange mutagenesis kit (Strat-
agene) according to the manufacturer’s instructions generating the plas-
mid pJM57-2. The oligos rSyn1A-C145Sf (GACTACCGAG AACGaTc-
gAA AGGGCGCATC CAGAGGC) and rSyn1A-C145Sr (GCCTCTG-
GAT GCGCCCTTTc gAtCGTTCTC GGTAGTC) were used for this
manipulation.
In a similar manner, the cytoplasmic domain of VAMP was obtained by
PCR with pJM27 (McNew et al., 1999) as a template and the oligos
mVAMP2-His
 
6
 
 (Weber et al., 1998) and mVAMP2-Cys (CCGGATCCTT
AGCAAAGCTT GAGGTTTTTC CACC). A NdeI–BamHI fragment
was ligated into pJM50 (McNew et al., 1999) generating pJM51. pJM50 is
a modified pET15b (Novagen) vector that has the HindIII site at bp 29–34
removed by digestion with HindIII, filling in with Klenow, and religated.
The final plasmid (pJM51) codes for VAMP2 without a TMD, but an ulti- 
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mate cysteine residue. This protein has no additional cysteine residues. A
VAMP protein with two COOH-terminal cysteines was also generated in
the same manner as above (pJM60). In this case, the PCR reaction con-
tained a new 3
 
9
 
 oligo, mVAMP2-C2 (CCGGATCCTT AGCAACCACC
GCAAAGCTTG AGGTTTTTCC ACC) that codes for the amino acids
Cys Gly Gly Cys. The protein resulting from this expression of pJM60 has
two cysteine residues spaced by two glycine residues (see Fig. 1).
Three SNAP-25b constructs were used in this study. pFP247 (Parlati
et al., 1999) expresses His
 
6
 
-SNAP-25b from pET-15b. A mutant SNAP-
25b that does not contain cysteine residues was constructed in the follow-
ing manner. A 40-bp AvrII–HindIII fragment was removed from pGEX-
mSNAP-25b (Weber et al., 1998) and replaced with a synthetic double-
stranded oligo (SN25C-Sf, CTAGGAAAAT TCTCCGGACT TTCCGT-
GTCC CCCTCCAACA, SN25C-Sr, AGCTTGTTGG AGGGGGACAC
GGAAAGTCCG GAGAATTTTC), generating pJM58. This dsOligo
mutates all four cysteine residues in the specified region of DNA to
serine. A His
 
6
 
-tagged version of this protein was constructed by removing
a 382-bp BamHI–AvrII fragment from pJM58 and ligating it into pFP247
cut with the same enzymes. The resulting plasmid (pJM72) expresses His
 
6
 
-
SNAP-25b [C85S, C88S, C90S, C92S].
 
Synthesis of Novel Maleimido Lipids
 
Maleimidopropionic Acid Undecaprenylester (C55). 
 
4 mg of undecaprenol
in carbon tetrachloride (Sigma-Aldrich) was dried down in a 1-ml reacti-
vial by a gentle stream of nitrogen and then dried under vacuum for 30
min. 2.25 mg maleoyl-
 
b
 
-alanine and 3.2 
 
m
 
g dicyclohexyl carbodiimde in 50 
 
m
 
l
dry ethylacetate each were added and the solution was stirred at room
temperature for 10 min. At this point, 5.2 
 
m
 
l of a 10-mM solution of
DMAP in dry ethylacetate was added, and stirring continued overnight at
room temperature. The slightly pinkish solution was applied to silica gel
TLC plate that was developed in methylene chloride/methanol (50:1). The
UV absorbing band with the highest R
 
f
 
 value (R
 
f
 
 5 
 
0.79) was scratched
out and eluted with ether. Evaporation of the eluent yielded 3.6 mg (75%)
of a colorless oil.
 
1
 
H-NMR spectra were recorded on a Bruker AMX-400 Mhz instru-
ment and referenced to CHCl
 
3
 
 (
 
1
 
H-NMR) 
 
d 5 
 
7.24. Mass spectra were re-
corded on a PE-Sciex Model API 100 instrument. IR spectra were re-
corded on Perkin Elmer 1600 series FT-IR spectrometer.
 
1
 
H-NMR (CDCl
 
3
 
): 
 
d 5 
 
1.6–1.75 (m, 36 H), 1.95–2.1 (m, 40 H), 2.63 (t,
2 H, J 
 
5 
 
7 Hz), 3.83 (t, 2 H, J 
 
5 
 
7 Hz), 4.56 (d, 2 H, J 
 
5 
 
7 Hz), 5.12 (br d,
10 H, J 
 
5 
 
4 Hz), 5.32 (t, 1 H, J 
 
5 
 
7 Hz), 6.69 (s, 2 H).
MS (electrospray): 940.9 (M
 
1 
 
1 
 
Na
 
1
 
), 952.8 (M
 
1 
 
1 
 
Cl
 
2
 
).
IR (CHCl
 
3
 
): 1712 (C
 
 5 
 
O), 1730 (C
 
 5 
 
O) cm
 
2
 
1
 
.
 
Maleimidopropionic Acid Solanesylester (C45). 
 
C45 was synthesized
from solanesol (Sigma-Aldrich) as described for C55, yield 75%.
 
1
 
H-NMR (CDCl
 
3
 
): 
 
d 5 
 
1.45–1.75 (m, 15 H), 1.95–2.10 (m, 12 H), 2.63 (t,
2 H, J 
 
5 
 
7 Hz), 3.83 (t, 2 H, J 
 
5 
 
7 Hz), 4.59 (d, 2 H, J 
 
5 
 
7 Hz), 5.11(br t,
3 H, J 
 
5 
 
6 Hz), 5.32 (t, 1 H, J 
 
5 
 
7 Hz), 6.70 (s, 2 H).
MS (electrospray): 804.5 (M
 
1 
 
1 
 
Na
 
1
 
), 816.6 (M
 
1 
 
1 
 
Cl
 
2
 
).
IR (CDCl
 
3
 
): 1712 (C
 
 5 
 
O), 1730 (C
 
 5 
 
O) cm
 
2
 
1
 
.
 
Maleimidopropionic Acid Geranylgeranylester (C20). 
 
C20 was synthe-
sized from geranylgeraniol (Metrya) as described for C55, yield 70%.
 
1
 
H-NMR (CDCl
 
3
 
): 
 
d 5 
 
1.5–1.75 (m, 30 H), 1.95–2.10 (m, 32 H), 2.64 (t,
2 H, J 
 
5 
 
7 Hz), 3.83 (t, 2 H, J 
 
5 
 
7 Hz), 4.59 (d, 2 H, J 
 
5 
 
7 Hz), 5.10 (br m,
3 H), 5.32 (t, 1 H, J 
 
5 
 
7 Hz), 6.70 (s, 2 H).
MS (electrospray): 442 (M
 
1 
 
1 
 
H
 
1
 
), 464.0 (M
 
1 
 
1 
 
Na
 
1
 
), 476.7 (M
 
1 
 
1
 
Cl
 
2
 
).
IR (CDCl
 
3
 
): 1712 (C
 
 5 
 
O), 1730 (C
 
 5 
 
O) cm
 
2
 
1
 
.
 
Maleimidopropionic Acid Farnesylester (C15). 
 
C15 was synthesized from
farnesol (Sigma-Aldrich) as described for C55, yield 61%.
 
1
 
H-NMR (CDCl
 
3
 
): 
 
d 5 
 
1.6 (s, 6 H), 1.68 (s, 6 H), 1.69, (s, 3 H), 1.85–
2.18 (m, 8 H), 2.64 (t, 2 H, J 
 
5 
 
7 Hz), 3.83 (t, 2 H, J 
 
5 
 
7 Hz), 4.59 (d, 2 HJ 
 
5
 
7 Hz), 5.07–5.11 (br m, 2 H), 5.31 (dt, 1 H, J 
 
5 
 
6 Hz, 1 Hz), 6.70 (s, 2 H).
MS (electrospray): 391.4 (M
 
1 
 
1 
 
NH
 
4
 
1
 
) 396.1 (M
 
1 
 
1 
 
Na
 
1
 
), 412.3 (M
 
1 
 
1
 
K
 
1
 
), 407.7 (M
 
1 
 
1 
 
Cl
 
2
 
).
IR (CHCl
 
3
 
): 1,712 (C
 
 5 
 
O), 1,730 (C
 
 5 
 
O) cm
 
2
 
1
 
.
 
Expression and Purification of t-SNARE Complex
 
A 100 ml preculture of BL21(DE3) cells transformed with plasmid
pTW34 (Parlati et al., 1999) was grown overnight at 37
 
8
 
C in Luria-Broth
(LB) medium containing 0.5% (wt/vol) glucose and 50 
 
m
 
g/ml kanamycin.
This preculture was used to inoculate a 12 l containing the same medium.
After overnight growth at 37
 
8
 
C, this culture was used to seed 300 liters
of LB medium containing 50 
 
m
 
g/ml kanamycin. The cells were grown until
 
they reached a density of 0.8 A
 
260
 
 and were then induced with IPTG (0.2 mM
final concentration). After 1 h at 37
 
8
 
C, an additional 15 g of kanamycin
sulfate was added and the incubation continued for an additional 3.5 h.
After centrifugation, the cell paste was frozen in liquid nitrogen in three
aliquots.
One aliquot of this cell paste (
 
z
 
900 g) was resuspended in 2 liters of
breaking buffer (25 mM Hepes-KOH, pH 7.40, 100 mM KCl, 10% [wt/vol]
glycerol and 10 mM 
 
b
 
-mercaptoethanol). After addition of 30 ml 200 mM
PMSF in ethanol and 500 ml 20% (wt/vol) Triton X-100, the cells were
disrupted by one passage through an Emulsiflex C5 cell disrupter (Aves-
tin) at 
 
.
 
10,000 psi. Cell debris was then removed by centrifugation in a
GS3 rotor for 30 min at 8,000 rpm. The supernatant was additionally clari-
fied by centrifugation in a Ti45 rotor for 45 min at 35,000 rpm. To this ly-
sate 30 ml packed Ni-NTA agarose (Qiagen) that have been washed first
in breaking buffer containing 1% (wt/vol) Triton X-100 and 500 mM imi-
dazole (pH adjusted to pH 7.5 with acetic acid) and then equilibrated with
breaking buffer containing 1% (wt/vol) Triton X-100. After mixing gently
overnight at 4
 
8
 
C on an orbital shaker, the slurry was poured into a column
and successively washed with 300 ml of breaking buffer containing 1%
(wt/vol) Triton X-100; breaking buffer containing 1% (wt/vol) n-octyl-
 
b
 
-
 
D
 
-glucopyranoside (OG); and breaking buffer containing 50 mM imida-
zole and 1% (wt/vol) OG. Finally, the t-SNARE complex was eluted with
a linear gradient (
 
z
 
250 ml) to breaking buffer containing 500 mM imida-
zole and 1% (wt/vol) OG. All fractions containing significant amounts of
t-SNARE complex were pooled. In an effort to remove heat-shock pro-
teins, 1 mM in MgCl
 
2
 
 and 100 mg ATP-agarose (Sigma-Aldrich) was
added to the pooled fractions. After overnight incubation at 4
 
8
 
C on a
turning wheel, the beads were removed by filtration and the t-SNARE
complex frozen in 550-
 
m
 
l aliquots that were stored at –80
 
8
 
C. The protein
concentration was determined according to Schaffner and Weissmann
(1973) using a bovine IgG as a standard, and was found to be 1.19 mg/ml.
Full-length mVAMP2 (pTW2) was purified as previously described
(Weber et al., 1998).
The soluble t-SNARE complex containing one modifiable cysteine
(SN25C-S/S
 
D
 
TMD-C) was produced by coexpression of pJM72 and
pJM57-2 in the BL21(DE3) 
 
Escherichia coli 
 
strain. 4 ml of prepreculture
of Luria-Broth (LB) containing 100 
 
m
 
g/ml ampicillin and 50 
 
m
 
l/ml kana-
mycin was inoculated with the coexpressing strain and grown at 37
 
8
 
C for
 
z
 
3 h. This 4-ml culture was used as the inoculum for a 1,200-ml preculture
of Super Broth (SB; Bio 101) containing 500 
 
m
 
g/ml ampicillin, 50 
 
m
 
g/ml
kanamycin, and 0.5% glucose. This preculture was grown overnight (12–
15 h) at 37
 
8
 
C. The 1,200-ml preculture was spun at 500 
 
g
 
 and the pelleted
cells resuspended in 24 liters of SB containing 200 
 
m
 
g/ml ampicillin and 50
 
m
 
g/ml kanamycin (4 l media in each of six baffled flasks). The 24-liter cul-
ture was grown to an OD
 
600
 
 of 
 
z
 
0.7, then induced with 1 mM IPTG for 4 h
at 37
 
8
 
C. The cells were harvested by centrifugation and resuspended in
100 ml of breaking buffer (25 mM Hepes-KOH, pH 7.7, 100 mM KCl,
10% (wt/vol) glycerol, 0.2 mM Tris(2-carboxyethyl)phosphine hydrochlo-
ride [TCEP; Fluka], and 2 EDTA-free protease inhibitor tablets [BM]).
The reducing agent TCEP was used to allow alkylation of the cysteine to
maleimide. The cells were disrupted by two passages though an Emulsi-
flex C5 cell disrupter. Cell debris was removed by centrifugation at
 
z
 
25,000 
 
g
 
 for 15 min. The supernatant was further clarified by a 60-min
centrifugation at 50,000 
 
g 
 
in a Ti70 rotor (Beckman). The supernatant
was added to 15 ml of packed Ni-NTA beads (Qiagen) equilibrated in
breaking buffer. Binding proceeded for 3 h at 4
 
8
 
C on a rotating wheel. The
slurry was spun at 
 
z
 
1,000 
 
g
 
 for 5 min and the majority of the unbound ma-
terial was removed. The beads were transferred to a 1.5 
 
3
 
 15-cm chroma-
tography column (BioRad). The beads were washed with wash buffer
(25 mM Hepes-KOH, pH 7.7, 200 mM KCl, 10% (wt/vol) glycerol, 0.2 mM
TCEP, 50 mM Imidazole-OAc, pH 7.5) until the A
 
280
 
 reached a stable
background (
 
z60 ml). The protein was eluted with a linear, 7-column vol-
ume imidazole (z100 ml) gradient from 50–500 mM. 3-ml fractions were
collected and analyzed by SDS-PAGE. Peak fractions were pooled and
frozen at 2808C in 300–500-ml aliquots. The protein concentration was
11.3 mg/ml as determined by a Bradford protein assay (Biorad) with IgG
as the standard.
The soluble t-SNARE complex containing up to five modifiable cys-
teines (SN25/SDTMD-C) was produced by coexpression of pFP247 and
pJM57-2 in the BL21(DE3) E. coli strain. The protein was purified as de-
scribed above.
The cytoplasmic domain of VAMP containing a COOH-terminal ulti-
mate cysteine was produced by expression of pJM51 in the BL21(DE3) E.
coli strain. A 200-ml preculture of SB containing 500 mg/ml ampicillin was
grown overnight at 378C. The cells were harvested by centrifugation and
used to inoculate 4 liters of 2XYT media containing 200 mg/ml ampicillin.The Journal of Cell Biology, Volume 150, 2000 108
The culture was grown at 378C until an OD600 of z0.7 was reached. Ampi-
cillin (100 mg/ml) was added to the growing culture every hour before in-
duction to prevent plasmid loss. The culture was induced with 0.2 mM iso-
propyl-b-D-thiogalactopyranoside for 4 h at 378C. The cells were harvested
by centrifugation and resuspended in 50 ml breaking buffer (25 mM
Hepes-KOH, pH 7.4, 400 mM KCl, 2 mM b-mercaptoethanol, 0.5 mM
4-(2-aminoethyl) benzenesulfonylfluoride, 1 EDTA-free protease inhibi-
tor tablet). The cells were disrupted by two passages though an Emulsiflex
C5 cell disrupter. Cell debris was removed by centrifugation at z25,000 g
for 15 min. The supernatant was further clarified by a 60 min centrifuga-
tion at 50,000 in an Ti70 rotor (Beckman). The supernatant was added to 3
ml of packed Ni-NTA beads (Qiagen) equilibrated in breaking buffer.
Binding proceeded for 1 h at 48C on a rotating wheel. The slurry was spun
at z1,000 g for 5 min and the majority of the unbound material was re-
moved. The beads were transferred to a 1.5 3 10-cm chromatography col-
umn (BioRad). The beads were washed with wash buffer (25 mM Hepes-
KOH, pH 7.4, 100 mM KCl, 10% [wt/vol] glycerol, 1 mM TCEP, 50 mM
Imidazole-OAc, pH 7.5) until the A280 reached a stable background (z15
ml). The protein was eluted with a linear, 7-column volume imidazole
(z20 ml) gradient from 50–500 mM. 1.5-ml fractions were collected and
analyzed by SDS-PAGE. Peak fractions were pooled and dialyzed against
4 l of 25 mM Hepes-KOH, pH 7.4, 100 mM KCl, 10% (wt/vol) glycerol, 1
mM TCEP. Significant precipitation occurred during dialysis. The dia-
lyzed material was spun at 60,000 for 15 min in a TLA100.3 rotor in a ta-
bletop ultracentrifuge (Beckman) to remove precipitates. The superna-
tant was frozen at 2808C in 100-ml aliquots. The protein concentration
was 9.9 mg/ml, as determined by an Amido Black protein assay (Schaffner
and Weissmann, 1973) with IgG as the standard.
The cytoplasmic domain of VAMP containing two COOH-terminal
cysteine residues and the cytoplasmic domain of rat VAMP2 was pro-
duced by the expression of pJM60 and pET-rVAMP2CD (Weber et al.,
1998), respectively, in the BL21(DE3) E. coli strain. The protein was puri-
fied as described for His6-mVDTMD-C, except the dialysis step was omit-
ted for His6-mVDTMD-C2.
All SDS-PAGE gels are standard 12% Laemmli gels (Laemmli, 1970),
except for Fig. 8, which is a 10% Bis-Tris NuPAGE gel (Novex).
SNARE Reconstitutions
The wild-type TMD-containing SNAREs were reconstituted essentially as
described (Weber et al., 1998). The primary exception was the t-SNARE
complex that was produced by coexpression of untagged syntaxin 1A and
His6-SNAP-25B (pTW34; Parlati et al., 1999). This t-SNARE complex re-
constitutes substantially better than the combination used previously,
likely because the COOH-terminal His6 tag has been removed from
syntaxin1A.
Lipid anchored t-SNARE complexes were also reconstituted by deter-
gent dilution and dialysis. 75 nmol (z5 mole percent) of the particular ma-
leimide lipid was dried in a 10 3 75-mm glass tube under a stream of nitro-
gen from a chloroform stock, and was then dried under vacuum for 30
min. The lipid film was resuspended by the addition of 25 ml of 20% (wt/
wt) OG, followed by 200–300 ml of protein solution (SN25C-S/SDTMD-C
or SN25/SDTMD-C), depending on the protein concentration. To this, 30
ml of 4 M KCl and the remaining volume up to 500 ml of reconstitution
buffer (without reducing agent) was added. The mixture was shaken on a
vortexer for 30 min at room temperature and then the incubation was con-
tinued for another 30 min standing. Unreacted maleimide lipid was
quenched by the addition of 5 ml of 100 mM b-mercaptoethanol for 10 min
at room temperature. The 500 ml solution of lipid-coupled protein was
transferred to another 10 3 75-mm glass tube containing 1,500 nmol of
lipid mix 5 g (85 mole% phosphatidylcholine [POPC], 15 mole% phos-
phatidylserine [DOPS]; 100 ml of 15 mM lipid in chloroform, dried as be-
fore). The lipid film was resuspended by vortexing the lipid/protein/deter-
gent solution for 15 min at room temperature. Proteoliposomes were
formed by diluting the detergent below its CMC with the addition of 1.0 ml
of reconstitution buffer (25 mM Hepes-KOH, pH 7.7, 100 mM KCl, 10%
[wt/vol] glycerol) containing 1 mM DTT. Detergent was removed by dial-
ysis in a GIBCO BRL microdialysis chamber against reconstitution buffer
containing 1 mM DTT at a flow rate of z1.5 ml/min for z15 h. Liposomes
were separated from unincorporated protein by flotation in a discontinu-
ous Nycodenz gradient as described in Weber et al. (1998).
Lipid-anchored VAMP was prepared by directly coupling VAMP-
DTMD-C to preformed, extruded liposomes containing the maleimide
lipid at 5 mole%. Liposomes were prepared by drying 300 nmol of partic-
ular maleimide lipid mix (77 mole% POPC, 15 mole% DOPS, 1.5 mole%
lissamine rhodamine B [rhodamine]-DPPE, 1.5 mole% nitro-2,1,3-ben-
zoxadiazole [NBD]-DPPE, 5 mole% of the maleimide lipid) in 10 3 75-mm
glass tubes under a stream of nitrogen from a chloroform stock, and then
dried under vacuum for 30 min. 300 ml of reconstitution buffer (without
reducing agent) was added to the dried lipid and the film was resuspended
by vortexing for 30 min at room temperature. The multilamellar lipo-
somes were frozen in liquid nitrogen for 30 s, and were then thawed in a
378C water bath for 30 s. This cycle was repeated eight times. Small unila-
mellar liposomes of z50 nm were produced by extrusion through 50-nm
polycarbonate filters using a Liposofast mini-extruder (Avestin). VAMP-
DTMD-C was coupled to the extruded liposome in a reaction containing
100 ml liposomes (z100 nmol lipid), 100 ml VAMPDTMD-C protein, and
100 ml Buffer B (25 mM Hepes-KOH, pH 7.7, 400 mM KCl, 10% [wt/vol]
glycerol, 2 mM EDTA). The reaction was mixed briefly by gentle vortex-
ing, and was then incubated at room temperature for 1 h with intermittent
gentle mixing. Continual mixing during the coupling reaction is detrimen-
tal to the final liposome preparation. Unreacted maleimide lipid was
quenched by the addition of 3 ml of 100 mM b-mercaptoethanol for 10 min
at room temperature. Liposomes were separated from unincorporated
protein by flotation in a discontinuous Nycodenz gradient as described
(Weber et al., 1998).
Fusion Assays and Data Analysis
Standard fusion assays were performed as described (Weber et al., 1998)
with modification (McNew et al., 1999). 45 ml (z100 nmol lipid, z660
pmol t-SNARE complex) of unlabeled t-SNARE liposomes were mixed
on ice with 5 ml (z 6.25 nmol lipid, z220 pmol VAMP) of fluorescently la-
beled v-SNARE liposomes in a 96-well Fluoronunc polysorp plate
(Nunc). The VAMP liposomes are essentially the same as described in
Weber et al. (1998), but the t-SNARE liposomes contain about two to
three times more protein, due to the increased reconstitution efficiency of
the improved His6-tagged SNAP-25/untagged syntaxin t-SNARE com-
plex. These reconstitution yielded z150 copies of the t-SNARE complex
per liposome. The plate was immediately placed in a 378C fluorescent
plate reader (Floroskan II; Labsystems) without any prior preincubation,
and NDB fluorescence was read (excitation 460 nm, emission 538 nm) at
2-min intervals. At the end of 120 min, 10 ml of 2.5%(wt/vol) n-docecyl-
maltoside (Boehringer) was added to determine NBD fluorescence at infi-
nite dilution. The kinetic fusion data was first converted to percent deter-
gent signal as described (Weber et al., 1998; McNew et al., 1999), and
was then converted to rounds of fusion using the equation: Y 5
0.49666*e(0.036031X) 2 0.50597*e(20.053946X), where Y is the fold lipid dilution
and X is the percent docecylmaltoside signal at a given time interval, as
described (McNew et al., 1999; Parlati et al., 1999).
Liposome Docking Assay
A Fluoronunc maxisorp plate was prepared for the docking assay in the
following manner. The HPC-1 monoclonal syntaxin antibody (100 ml of
100 mg/ml of purified IgG in PBS) was added to wells of the 96-well micro-
titer plate and allowed to bind for 1 h at room temperature on a rocking
platform. Unbound IgG was washed away with three 300 ml washes with
PBS. Nonspecific protein binding was blocked by the addition of 300 ml of
10 mg/ml bovine IgG (Calbiochem) in PBS for 1 h at room temperature
on a platform. Residual IgG was removed with five 300 ml washes with
PBS. Nonspecific lipid binding was prevented by the addition of 50 ml of
3 mM small unilamellar liposomes (SUV’s, 85 mole% POPC, 15 mole%
DOPS in reconstitution buffer, prepared by sonication). Bulk lipid bind-
ing continued for 1 h at room temperature on a platform. At this time, 10 ml
of the blocking liposomes was removed and replaced with a mixture of 1:1
unlabeled t-SNARE liposomes and labeled v-SNARE liposomes that
were docked overnight at 48C in a 500-ml microfuge tube. 30 ml of each v-
and t-SNARE liposomes (60 ml total) were allowed to dock overnight.
Where indicated, 5 ml (z15 mg) of competitor VAMP-soluble domain was
added to inhibit docking. 10 ml of this mixture (five v- and five t-SNARE)
was added to wells (five replicates) of a 96-well microtiter plate for each
docking pair. Adherence of the docked liposomes was done for 1 h at
room temperature on a platform. Undocked v-SNARE–containing lipo-
somes were removed by five 300 ml washes with PBS. The remaining
docked, v-SNARE–derived rhodamine fluorescence was determined by
solubilizing the remaining lipid in 100 ml of 2% SDS and measuring
rhodamine fluorescence (excitation 535 nm, emission 590 nm, emission
cutoff at 570 nm) in a fluorescent plate reader (SpectraMax Gemini, Mo-
lecular Devices). The data presented in Figs. 2 and 4 are the average of
five wells and the error bars show SD from the mean.McNew et al. Proximity Alone Does Not Drive Membrane Fusion 109
Results
Covalent Attachment of SNARE Cytoplasmic Domains 
to Lipids and the Fusion Assay
The cytoplasmic (soluble) domains of VAMP2 and syn-
taxin1A were expressed in E. coli and then attached to a
maleimide derivative of a lipid moiety via the SH group of
a unique, engineered cysteine residue (Fig. 1 A). The sole
cysteine residue (position 145) in the native sequence of
syntaxin1A was replaced by a serine by in vitro mutagene-
sis. VAMP2 normally lacks cysteine in the cytosolic do-
main. For certain experiments, the four (naturally palmi-
toylated) cysteines in SNAP-25 were also replaced with
serines by mutagenesis (Fig. 1 A). The location of a single
cysteine at the COOH terminus of VAMP2 and syn-
taxin1A assures that proteins will be attached to lipids in
bilayers with the same orientation as when they are linked
to their natural peptidic anchors. Cytoplasmic domains of
syntaxin and SNAP-25 (or related constructs) were coex-
pressed in E. coli and the resulting soluble t-SNARE com-
plex was purified from these extracts (Weber et al., 1998).
As one lipid moiety to anchor soluble VAMP and/or
syntaxin/SNAP-25, we employed a commercially available
maleimide derivative of phosphatidylethanolamine (Fig. 1
B). In addition, we synthesized four isoprenoid derivatives
of varying chain lengths: 15 carbons (farnesyl); 20 carbons
(geranylgeranyl); 45 carbons (solanesyl); and 55 carbons
(undecaprenyl). Farnesyl and geranylgeranyl are used bio-
logically to anchor otherwise soluble proteins (Fu and Ca-
sey, 1999). Undecaprenol (also termed ficaprenol-11) is
used biologically to anchor intermediates in the synthesis
of oligosaccharide chains in bacteria (Troy, 1979; Reusch,
1984). A maleimide group attached to a linker was added
to the terminal OH of the isoprenoids as described in Ma-
terials and Methods.
The conjugate that results from the attachment of the
lipid anchor to the SNARE can then be use in the forma-
tion of proteoliposomes. In all cases, the location of the
modifiable cysteine (the point of attachment of lipid an-
chor; Fig. 1 A) is immediately following the membrane-
delimiting lysine residue. This placement puts the SNARE
in a very similar position relative to the membrane as its
native TMD counterpart. The short linker that bridges the
final cysteine residue in the protein to the lipid anchor
(z18 Å in the maleimide phosphatidylethanolamine de-
rivative [PE] lipid anchor and z9 Å in the isoprenoid lip-
ids) is well within the tolerance of normal membrane fu-
sion identified by proteinaceous linkers (9 amino acids,
z30 Å in an extended conformation; McNew et al., 1999).
The fusion activity of the full-length protein-anchored
and the lipid-anchored soluble SNARE proteins was mon-
itored by the well-characterized lipid-mixing assay de-
scribed in detail previously (Struck et al., 1981; Weber et al.,
1998). Two populations of vesicles containing VAMP
(v-SNARE or donor vesicles) and the syntaxin-SNAP-25
complex (t-SNARE or acceptor vesicles) are reconstituted
by detergent dialysis in the presence of excess phospholip-
ids (85 mole% POPC and 15 mole% DOPS). The vesicles
containing the v-SNARE were labeled by including 1.5
mole% of each of the fluorescent lipids NBD-PE and
rhodamine-PE at the expense of POPC in the reconstitu-
tion. The fluorescence of NBD is quenched by rhodamine
in an energy transfer process that is strongly dependent on
distance. Therefore, when fluorescent v-SNARE vesicles
fuse with unlabeled t-SNARE vesicles, fluorescent lipids
are diluted, the average distance between the fluorophores
increases, and NBD fluorescence increases as quenching is
relieved. This effect is monitored at the NBD emission
maximum at 538 nm and normalized to infinite lipid dilu-
tion by detergent addition. The normalized fluorescent
signal is converted to rounds of donor vesicle fusion after
the calibration procedure previously described (McNew
et al., 1999; Parlati et al., 1999).
SNAREs Anchored by a Single Phospholipid neither 
Fuse nor Hemifuse
v-SNARE liposomes were produced that contained VAMP
Figure 1. Neuronal SNARE proteins and lipid structures. A, The
domain structure of the full-length SNARE proteins are graphi-
cally depicted. In modified regions, the amino acid sequence
is shown to expose the exact nature of the changes. v- and
t-SNAREs were constructed that were lacking the TMDs and
terminated in an ultimate cysteine residue. To produce t-SNARE
complexes containing only one modifiable cysteine residue, the
naturally occurring cysteines in SNAP-25 were removed by site
directed mutagenesis. B, The structure of a commercially avail-
able PE and four novel synthetic isoprenyl lipids are shown.The Journal of Cell Biology, Volume 150, 2000 110
that was attached to the bilayer either by its native TMD or
by the PE derivative (Fig. 1 B). Donor liposomes (POPC,
DOPS, NDB-PE, and rhodamine-PE, z50 nm) that con-
tained 5 mole% of the maleimide-PE derivative were pre-
pared by extrusion through polycarbonate filters. VAMP
was coupled directly to the preformed liposomes in solu-
tion. The coupling reaction was terminated and excess
maleimide lipid was quenched by the addition of 1 mM
b-mercaptoethanol to the reaction. The amount of VAMP
added to the coupling reaction was empirically determined
to parallel the yield of full-length VAMP reconstituted by
detergent dilution and dialysis (Fig. 2 C). Unmodified
VAMP did not significantly associate with the resulting li-
posomes. The extent of coupling was monitored by a shift
in molecular weight associated with lipid coupling.
Similarly, liposomes containing the t-SNARE complex
syntaxin1A/SNAP-25 were prepared where syntaxin was
attached to the membrane via its native TMD, or with the
single PE lipid anchor. This was accomplished by coex-
pressing syntaxin1A without its TMD and with the sole
cysteine at its COOH terminus (SDTMD-C) together with
a mutant version of SNAP-25 without any cysteines (SN25
C-S, Fig. 1 A). This soluble t-SNARE complex was at-
tached to maleimide-PE in detergent solution and used in
normal reconstitution by detergent dilution and dialysis.
We confirmed that the SN25 C-S was completely func-
tional for fusion when coexpressed with the TMD-contain-
ing syntaxin and tested with TMD-anchored VAMP (data
not shown). Fusion activity was assayed at 378C (with no
preincubation) using all possible combinations of PE and
TMD-anchored v- and t-SNAREs (Fig. 2). Importantly,
VAMP attached with maleimide-PE lacked significant fu-
sion activity when tested with the TMD-linked t-SNARE
syntaxin/SNAP-25 (Fig. 2; open circles). The same result
was obtained when the t-SNARE was anchored by PE and
these liposomes were tested with TMD-linked v-SNARE
liposomes (filled diamonds). These results show that a
phospholipid anchor on either v- or t-SNARE prevents fu-
sion. These results also demonstrate that there is no signif-
icant hemifusion (mixing of outer, but not inner leaflets),
since partial lipid mixing was not observed.
Phospholipid-anchored SNAREs Dock Vesicles
To confirm that the PE-linked SNAREs could still form
SNARE complexes pinning donor and acceptor vesicles
together, even though they failed to fuse, we developed a
liposome docking assay that measures the amount of fluo-
rescently labeled v-SNARE donor liposomes that are
bound to unlabeled t-SNARE acceptor liposomes. For this
purpose the v- and t-SNARE liposomes were allowed to
dock (Weber et al., 1998), then the t-SNARE liposomes
were selectively retrieved by immunoisolation. Fluores-
cence associated with the isolated t-SNARE vesicles
(above controls for nonspecific binding) reflects bound
v-SNARE vesicles. Selective recovery was accomplished
by coating microtiter plates with an mAb (HPC-1; Inoue et
al.,  1992) that specifically recognizes the NH2-terminal
regulatory domain of syntaxin1A, which is not involved in
the core complex (Sutton et al., 1998).
Fig. 2 B shows the results of the liposome docking assay
that clearly demonstrate that both PE-linked v-SNAREs
Figure 2. Proximity alone is not sufficient to fuse SNARE-con-
taining vesicles. A, The TMD of either VAMP or syntaxin was
replaced with a modifiable cysteine residue (Fig. 1). These pro-
teins were produced in bacteria and coupled in vitro to maleim-
ido-PE (Fig. 1) through a thioether linkage. The t-SNARE com-
plex was produced by coexpression of syntaxin (SDTMD-C) with
SN25 C-S. This t-SNARE complex contains only one modifiable
cysteine residue located at the COOH terminus of syntaxin. The
lipid-anchored proteins were incorporated into vesicles by deter-
gent dilution and dialysis (t-SNARE complex) or coupled di-
rectly to preformed vesicles containing 5 mole% maleimide-PE
(VAMP). Vesicles containing the lipid-anchored or normal
SNAREs were mixed on ice in various combinations and incu-
bated for 120 min at 378C in a standard fusion reaction. The ex-
tent of fusion is represented as rounds of fusion measured as fold
lipid dilution in the reaction. Full-length TMD syntaxin fuses
with TMD VAMP to wild-type levels (closed circle). VAMP with
a single PE attachment does not lipid mix with wild-type TMD
syntaxin (open circles). Similarly, t-SNARE complexes with a
single PE attachment do not lipid mix with TMD VAMP (filled
diamonds). When both SNARE partners are attached with a sin-
gle PE lipid anchor, little or no lipid mixing is observed (open
diamonds). B. Liposome docking assay. v- and t-SNARE
liposomes were incubated in a 1:1 mixture. The t-SNARE–con-
taining liposomes were bound to microtiter plates via an interac-
tion with preciously attached HPC-1 antibodies (see Materials
and Methods). Unbound liposomes were removed by washing
with PBS and docked v-SNARE liposomes were detected by
determining plate-bound rhodamine fluorescence after detergent
solubilization. The amount of VAMP liposome-derived rho-
damine fluorescence retained on the plate is expressed as the av-
erage of five wells for each condition with the error bars repre-
senting SD. C, Coomassie blue-stained gel of the vesicles used in
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and t-SNAREs are capable of mediating vesicle docking.
In fact, the lipid-anchored liposomes show an enhanced
ability to dock. This enhanced docking efficiency could be
explained by an increased conformational freedom of the
lipid-attached SNAREs, which in turn would favor trans-
SNARE complex formation between liposomes. The spec-
ificity of the docking reaction was confirmed by the ability
of soluble VAMP to effectively inhibit docking of lipo-
somes containing either VAMP anchored by its transmem-
brane region (Fig. 2 B) or lipid-anchored VAMP (data not
shown). The observation that PE-linked SNAREs dock
vesicles also rules out the possibility that sufficient force is
generated by SNARE assembly to uproot one lipid an-
chored SNARE from its bilayer and drive its insertion into
the other bilayer housing a TMD-anchored SNARE.
The docking results imply that PE-anchored SNARE
complexes can form between vesicles without fusion. Since
the small difference in linker length between the PE- and
TMD-linked SNAREs outside of the bilayer is well within
the tolerance for fusion (McNew et al., 1999), SNARE-
dependent fusion follows an active mechanism. Proximity,
though a prerequisite, is not sufficient.
Polyisoprenoid Anchors that May Span the Membrane 
Can Link SNARE Assembly to Bilayer Mixing
Since proximity is not by itself sufficient for bilayer fusion,
it follows that in one or another way SNAREpins func-
tional in fusion exert force in the bilayer, pushing it or its
constituent lipids along the pathway towards fusion. Evi-
dently, the native TMD was selected in evolution at least
in part because it could effectively transduce this force. Is
it possible that other lipid anchors, if not PE, might be able
to transduce force and thus permit fusion after SNAREpin
assembly?
One obvious difference between PE and a TMD is the
depth of bilayer penetration. A phospholipid spans only
half the bilayer, while a TMD spans all of it. If this differ-
ence accounts for the loss of fusion activity, then fusion
activity should be observed when SNAREs are linked to
lipids that are anchored in both leaflets. With the excep-
tion of some rare archaebacterial lipids (Sprott, 1992),
phospholipids are not known in nature that have the ca-
pacity to span both leaflets. Therefore, to test this possi-
bility we chose the 55-carbon isoprenoid undecaprenol
(C55). Though, to our knowledge, it has never been for-
mally shown that undecaprenol spans the bilayer, this is
strongly suggested by its length, z52 Å when fully ex-
tended, as compared with the thickness of most bilayers of
35–40 Å. The terminal OH of undecaprenol was esterified
with N-malonyl b-alanine to yield the desired lipid, C55
(Fig. 1 B, and Materials and Methods). The linker length
of this lipid (including the sulfur of the COOH-termi-
nal cysteine of the attached SNARE) is estimated to be
z8–9 Å. Soluble SNAREs were attached to this maleim-
ide lipid as described for the maleimide-PE derivative.
Coupling conditions were chosen that ensured similar re-
constitution efficiencies of the C55-coupled and wild-type
SNAREs (Fig. 3 C).
Fusion assays (Fig. 3 A) reveal that both C55-anchored
v-SNARE and t-SNARE are active with their TMD-
linked cognates, and even lipid mix with each other to a
significant extent. Remarkably, the C55 lipid-anchored
v-SNARE fuses with the TMD-linked t-SNARE substan-
tially better than does the native TMD-linked v-SNARE.
This is likely the result of increased flexibility in the jux-
tamembrane region afforded by the lipid anchor. These
surprising results show that lipid mixing comparable to
native SNARE proteins still occurs, even when both v-
and t-SNAREs are attached via lipid anchors, implying
Figure 3. Lipid anchors can functionally substitute for a pro-
teinaceous TMD. A, The TMD of either VAMP or syntaxin was
replaced with a modifiable cysteine residue (Fig. 1). These pro-
teins were produced in bacteria and coupled in vitro to C55 (Fig.
1) through a thioether linkage. The t-SNARE complex was pro-
duced by coexpression of syntaxin (SDTMD-C) with SN25 C-S.
This t-SNARE contains only one modifiable cysteine residue lo-
cated at the COOH terminus of syntaxin. The lipid-anchored
proteins were incorporated into vesicles by detergent dilution
and dialysis (t-SNARE complex) or coupled directly to pre-
formed vesicles containing 5 mole% C55 (VAMP). Vesicles con-
taining the lipid-anchored or normal SNAREs were mixed on ice
in various combinations and incubated for 120 min at 378C in a
standard fusion reaction. The extent of fusion is represented as
rounds of fusion measured as fold lipid dilution in the reaction.
Full-length TMD syntaxin fuses with TMD VAMP to wild-type
levels (closed circle). VAMP with a single C55 attachment fuses
z40% better than wild-type with TMD syntaxin (open circles).
t-SNARE complexes with a single C55 attachment fuses to near
wild-type levels with TMD VAMP (filled diamonds). Most sur-
prisingly, when both vesicle populations contain lipid-anchored
SNAREs, wild-type levels of fusion are still observed (open dia-
monds). B, Liposome docking assay (see Fig. 2). C, Coomassie
blue-stained gel of the vesicles used in the fusion reactions.The Journal of Cell Biology, Volume 150, 2000 112
that the undecaprenol anchors can transduce force from
the SNARE complex into the bilayer.
Routinely, 50 nm v-SNARE liposomes are prepared to
allow a direct comparison with liposomes containing TMD-
linked VAMP. When VAMP was coupled to liposomes
prepared by extrusion through 200-nm polycarbonate fil-
ters, fusion also resulted upon incubation with z50-nm
TMD-linked t-SNARE liposomes (Fig. 4). Unfortunately,
it was not possible to test larger t-SNARE liposomes since
the t-SNARE complex was not efficiently coupled to pre-
formed liposomes.
To determine if chain length is the critical determinant
of the ability of C55 isoprenoid anchors to couple SNARE
assembly to fusion, polyisoprenoids of differing chain
lengths were tested. Fig. 5 provides these results. Neither
C15 nor C20 anchors promote lipid mixing, but they do
dock liposomes (data not shown). Neither of these lipid
anchors is long enough to penetrate both leaflets. The C45
anchor behaved identically to the C55 anchor, allowing
lipid mixing to nearly twice the extent of TMD-linked
SNAREs. Since there are no differences among this ho-
mologous series in the cytoplasmic or linker regions, or
even at the bilayer interface, it is clear that chain length is
the sole factor that enables the longer anchors to couple
fusion (lipid mixing) to SNARE assembly, and that ac-
counts for the inability of shorter lipid chains to do so.
The fact that C55 and C45 anchors allow lipid mixing to
the same or greater extent than TMD-linked SNAREs im-
plies that a complete fusion reaction has occurred with
these lipid anchors, as has been independently docu-
mented for TMD-linked SNAREs by separately measur-
ing inner leaflet mixing after selective reduction of outer
monolayer NBD-PE by dithionite (Weber et al., 1998) and
by contents mixing (Nickel et al., 1999). Hemifusion, by
definition, would have resulted in a smaller signal. Unfor-
tunately, we have not been able to confirm complete fu-
sion using either of the above assays because the C45 and
C55 maleimide derivatives render even unfused liposomes
leaky to dithionite, and even to oligonucleotides (data not
shown).
Since not all PE or isoprenoid derivatives present in the
donor or acceptor liposomes are actually attached to
SNAREs (i.e., they are added in excess to promote effi-
cient coupling of protein) it was important to rule out the
unlikely possibility that the presence of the uncoupled
maleimide lipid derivatives in the lipid bilayer has a signif-
icant effect on promoting or inhibiting normal SNARE-
mediated fusion. Control experiments confirmed that con-
centrations up to 5 mole% of either PE (data not shown)
or C55 (quenched with 1 mM b-mercaptoethanol) had no
Figure 4. Larger vesicles containing C55-linked VAMP are fusion
competent. VAMP (VDTMD-C) was coupled in vitro to pre-
formed liposomes containing 5 mole% C55 extruded through ei-
ther 50- or 200-nm polycarbonate filter. Protein-free 200-nm lipo-
somes containing 5 mole% C55 were also prepared. Vesicles
containing the lipid-anchored v-SNAREs were mixed on ice with
wild-type  z50-nm TMD-containing t-SNARE liposomes, and
were then incubated for 120 min at 378C in a standard fusion
reaction. The extent of fusion is represented as fold lipid dilution
since the size assumption for the rounds of fusion calibration is
not valid. Full-length TMD VAMP fuses to wild-type levels
(closed circle). VAMP coupled to 50-nm vesicles fused substan-
tially better than wild-type (open circles). VAMP coupled to
200-nm vesicles fused better than wild-type, however, not to the
same extent as 50-nm vesicles (filled diamond), likely due to the
probe-dilution nature of the assay. Protein-free 200-nm lipo-
somes containing C55 did not fuse with acceptor liposomes. Mor-
phological analysis by cryoelectron microscopy confirmed that
the liposome extruded through 200-nm filters were larger than
those with 50-nm filters.
Figure 5. Short isoprenoid lipids do not lipid mix. A, VAMP
(VDTMD-C) was coupled in vitro to preformed liposomes con-
taining 5 mole% of either the PE lipid-anchor or one of four dif-
ferent isoprenoids of increasing length. Vesicles containing the
lipid-anchored v-SNAREs were mixed on ice with wild-type
TMD-containing t-SNARE liposomes, and were then incubated
for 120 min at 378C in a standard fusion reaction. The extent of
fusion is represented as rounds of fusion measured as fold lipid
dilution in the reaction. Full-length TMD VAMP fuses to wild-
type levels (closed circle). All of the short lipid anchors (up to
and including C20) show little or no ability to lipid mix. The
longer lipid anchors, C45 (closed squares) and C55 (open
squares), lipid mix to a similar extent (z75% better than wild-
type). B, Coomassie blue-stained gel of the vesicles used in the
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significant effect. Fig. 6 shows that quenched C55 (C55*)
has a marginal inhibitory effect when incorporated at 5
mole% in the acceptor t-SNARE liposomes containing
the t-SNARE complex. Donor liposomes containing PE-
linked VAMP and 5 mole% quenched C55* were still un-
able to generate a fusion signal, demonstrating that the
long-chain C55 isoprenoid is not inherently fusogenic or
fusion-promoting on its own.
Asymmetric Lipid Anchor Requirements for
v- and t-SNAREs
A careful analysis of the lipid mixing activity of various
lipid-anchored SNAREs revealed distinct requirements
for v- and t-SNAREs. In the native t-SNARE complex,
the SNAP-25 component contains four conserved cysteine
residues that are normally fatty-acylated in vivo (Hess
et al., 1992; Veit et al., 1996). Unless these residues are
purposefully removed (as in the experiments reported
above), they too should be modified with lipid during the
coupling reaction, resulting in t-SNAREs anchored by
multiple lipids: one at the extreme COOH terminus of
syntaxin and up to four attachments in the cysteine loop
region of SNAP-25. When this t-SNARE complex is cou-
pled to PE, it retains significant capacity to lipid mix
with TMD-linked v-SNARE (z50% of the TMD-linked
t-SNARE; Fig. 7 A, filled diamonds). Because even five
attached PE molecules cannot span the bilayer, the com-
mon factor between the ability of C45–55 and multiple PE
attachments is not bilayer penetration, but rather appears
to be overall hydrophobicity as the critical factor in deter-
mining t-SNARE anchor activity.
The attachment of multiple PE molecules in the above
experiments was confirmed by the significant gel shift of
wild-type SNAP-25 relative to the C-S mutant (Fig. 7 B).
A t-SNARE complex anchored to membrane only by PE-
linked SNAP-25 (presumably involving up to four PE mol-
ecules per SNAP-25, made using a syntaxin cytoplasmic
domain lacking any cysteine) is also fusogenic (data not
shown).
To see if increasing the overall hydrophobicity (with an-
chors exclusively in the outer leaflet) would also create a
v-SNARE competent for lipid mixing, soluble VAMP con-
structs with several cysteines at the COOH terminus were
produced to test the requirements on the v-SNARE side.
When a VAMP with two cysteines (Fig. 1 A, VDTMD-C2)
Figure 6.  C55 does not stimulate or inhibit SNARE mediated fu-
sion. Vesicles containing the indicated SNAREs were mixed on
ice, and were then incubated for 120 min at 378C in a standard fu-
sion reaction. The extent of fusion is represented as rounds of fu-
sion measured as fold lipid dilution in the reaction. Lipid mixing
is seen with vesicles containing TMD-containing SNAREs and
the standard lipid composition (filled circles). Similar rates and
extents of mixing are seen when the t-SNARE acceptor popula-
tion contains 5 mole% C55 (quenched with b-mercaptoethanol,
open circles, C55*). When donor liposomes containing PE-linked
VAMP are used (filled diamonds), the presence of 5 mole%
quenched C55 does not stimulate lipid mixing (open diamonds,
C55*).
Figure 7. Asymmetric lipid anchor requirements. Overall
amount of hydrophobicity is important for the t-SNARE com-
plex. A, Syntaxin (SDTMD-C) was coexpressed with either SN25
C-S or wild-type SNAP-25, producing t-SNARE complexes with
either a single modifiable cysteine residues or a complex with five
modifiable residues. These proteins were coupled in vitro to the
PE lipid-anchor generating t-SNARE complexes with varying
amounts of hydrophobicity. The lipid-anchored proteins were in-
corporated into vesicles by detergent dilution and dialysis. Vesi-
cles containing the lipid-anchored t-SNAREs were mixed on ice
with wild-type TMD-containing VAMP liposomes, and were
then incubated for 120 min at 378C in a standard fusion reaction.
The extent of fusion is represented as rounds of fusion measured
as fold lipid dilution in the reaction. Full-length TMD syntaxin
fuses to wild-type levels (closed circle), whereas t-SNARE com-
plexes with a single PE attachment (open circles) show no fusion
above protein-free liposomes (open diamonds). However, the
t-SNARE complex with multiple PE attachments (up to five,
filled diamonds) fuses to z50% of wild-type levels. B, Coomassie
blue-stained gel of the vesicles used in the fusion reactions.The Journal of Cell Biology, Volume 150, 2000 114
is coupled to PE, little or no lipid mixing is observed with
acceptor liposomes containing TMD-linked t-SNAREs
(Fig. 8 A, open diamonds). The same was true when the
VAMP had four COOH-terminal cysteines (not shown).
However, when these same v-SNAREs are anchored by
C55, bilayer mixing now occurs (data not shown). These
results suggest that while overall hydrophobicity deter-
mines t-SNARE anchor activity, chain length determines
v-SNARE anchor activity.
Discussion
The Role of TMDs in SNARE-dependent
Membrane Fusion
It is likely that the TMDs of SNARE and viral fusion pro-
teins have an important role in membrane fusion. All
VAMP or syntaxin-type SNARE proteins identified to
date, with one notable exception have a COOH-termi-
nal TMD. Even the exception (the yeast SNARE Ykt6p
and its homologues (McNew et al., 1997) is membrane-
anchored at its COOH terminus by an encoded polyiso-
prenoid. Viral fusion proteins, and some SNAREs, have
certain common and characteristic features in the place-
ment of glycines residues within their transmembrane an-
chors and point mutations in these and other regions of
the TMD have been found to affect fusion (Owens et al.,
1994; Cleverley and Lenard, 1998; Melikyan et al., 1999).
Also, replacing the TMD with a GPI lipid anchor prevents
fusion (Kemble et al., 1994; Melikyan et al., 1995). While
these data are certainly consistent with an active role for
the natural peptidic anchors in force transduction required
for fusion, other interpretations cannot be rigorously ex-
cluded due to the inherent complexity of the viral fusion
proteins and, in some cases, the assays employed as dis-
cussed in the Introduction.
It is more straightforward to address the basic issue of
whether anchors play a passive or an active role in fusion
in the context of SNARE proteins. This system is inher-
ently more tractable to modification because the SNARE-
pin functional in fusion assembles from two separate parts,
two half pins, during the fusion process. As a result, the
v-SNARE and t-SNARE can be separately modified and
all combinations can be directly tested. By contrast, the vi-
ral hairpin implicated as fusogenic assembles intramolecu-
larly only in the context of a complex refolding reaction in
a much larger protein (Wilson et al., 1981; Carr and Kim,
1993; Bullough et al., 1994; Skehel and Wiley, 1998). Also,
since the assay for fusion activity involves isolated recom-
binant SNARE proteins, a variety of distinct lipidic an-
chors can be added to already folded and purified cyto-
plasmic proteins by chemical modification. Additionally,
the diversity of the attached lipid anchors is not limited to
the few moieties whose addition is encodable on a given
side of a membrane in living cells.
The fact that lipid mixing is not observed when either a
v-SNARE or a t-SNARE (or both) are anchored to a
single phospholipid argues forcefully against a passive
mechanism because the same SNARE complex is involved
and bilayer proximity is not significantly altered. Lack of
lipid mixing means that neither complete fusion (involving
both leaflets of both vesicles), nor hemifusion (involving
outer leaflets only) takes place. Yet trans-SNARE com-
plexes, in which v-SNAREs anchored in one bilayer as-
semble into helical bundles with t-SNAREs anchored in
another, must still form because vesicles still dock. This
means that donor and acceptor vesicles held together by
the same SNARE complex fuse when both have their nor-
mal peptidic anchors, but fail to fuse when either peptidic
anchor is replaced by a phospholipid. Furthermore, the
two vesicles are held in functionally indistinguishable and
structurally similar proximity, since incidental changes in
Figure 8. Asymmetric lipid anchor requirements. Length of the
hydrophobic component is important for v-SNAREs. A, VAMP
(VDTMD-C) was coupled in vitro either to the PE lipid anchor
or the longer C55 isoprenoid. Additionally, another VAMP pro-
tein was made that contained two cysteine residues at its COOH
terminus (Fig. 1). This protein was produced to generate VAMP
with multiple attachment points, similar to the t-SNARE com-
plex in Fig. 7. The VAMP proteins were coupled directly to pre-
formed vesicles containing 5 mole% C55, or 5 mole% PE as indi-
cated. Vesicles containing the lipid-anchored v-SNAREs were
mixed on ice with wild-type TMD-containing t-SNARE lipo-
somes, and were then incubated for 120 min at 378C in a standard
fusion reaction. The extent of fusion is represented as rounds of
fusion measured as fold lipid dilution in the reaction. Full-length
TMD VAMP fuses to wild-type levels (closed circle). As seen in
Fig. 3, VAMP coupled to the C55 lipid anchor fuses better than
wild-type (open circles). However, VAMP with a single PE at-
tachment (filled diamonds) shows no fusion above protein-free
liposomes (filled squares). Interestingly, VAMP with multiple
PE attachments (open diamonds) shows no ability to fuse in con-
trast to a similarly anchored t-SNARE complex. Additional ex-
periments show that even four PE lipid anchors added to VAMP
do not significantly increase its fusion potential (data not shown).
B, Coomassie blue-stained gel of the vesicles used in the fusion
reactions.McNew et al. Proximity Alone Does Not Drive Membrane Fusion 115
linker length associated with changing peptidic to lipid an-
chors are without significant effect on fusion (McNew et al.,
1999). The linkers that attach the cytoplasmic domain of
the SNARE proteins to these phosphatidylethanolamine
headgroups (including the COOH-terminal cysteine of the
VAMP or syntaxin) are z18 Å long when fully extended.
This linker length is well within the variations that have
been shown to be well-tolerated with no significant ad-
verse affect on VAMP fusion activity (McNew et al.,
1999). Therefore, the dramatic loss of fusion activity when
peptidic anchors are replaced by a phospholipid is not due
to incidental variations in linker length, but rather to
change in anchor unit.
In sum, two bilayers held together by the same device
fuse with peptidic anchors, but not with phospholipid an-
chors. If spontaneous fluctuations in bilayer lipids were to
drive fusion in a passive mechanism, the sole role of the
SNARE complex would be to create adequate proximity
without interacting with (i.e., exerting force to) membrane
lipids. This state would be created as well with phospho-
lipid anchors as with peptidic anchors, and would result in
fusion after docking; it does not do so. The fact that even
intimate bilayer proximity is not sufficient to promote fu-
sion adds further weight to the already considerable evi-
dence that SNAREpins utilize a specific and biologically
relevant mechanism to promote fusion (Weber et al., 1998;
Chen et al., 1999; McNew et al., 1999; Nickel et al., 1999;
Parlati et al., 1999; Weber, T., F. Paralti, J.A. McNew, R.J.
Johnston, B. Westermann, T.H. Söllner, and J.E. Roth-
man, manuscript submitted for publication) and do not
simply dock membranes that then fuse by an unknown
mechanism (Ungermann et al., 1998).
The finding that replacement of certain viral TMDs
with a GPI-based phospholipid anchor abrogates fusion
(Kemble et al., 1994; Melikyan et al., 1995) is consistent
with our result with SNAREs; however, it is not clear why
in the viral case a hemifusion process is created (or per-
sists), whereas with SNAREs no fusion process remains.
Conceivably this difference relates to the fact that a fusion
peptide is not a traditional TMD since it can reside either
folded within a larger protein or associated with a cellular
membrane. Even then, the fusion peptide may or may not
penetrate both leaflets of the cellular membrane; the ge-
ometry of its interaction with the bilayer has been the sub-
ject of much debate (Durell et al., 1997; Pecheur et al.,
1999; Peuvot et al., 1999). By contrast, v- and t-SNAREs
must each have a permanent and traditional membrane
anchor since they reside in separate membranes before fu-
sion. If the fusion peptide penetrates the outer leaflet, but
not the inner leaflet, it could displace sufficient lipids to al-
low hemifusion (Chernomordik et al., 1998, 1999; Bentz,
2000); this could point to a difference in force transduction
mechanisms between viral and SNARE-dependent fusion.
Possible Mechanisms for Active Coupling of SNARE 
Assembly to Motion in the Bilayer Promoting Fusion
Our results clearly imply that assembly of the SNAREpin
must in one way or another do work on the bilayer to pro-
mote fusion, either during or after its assembly. This cou-
pling could occur during assembly, when free energy is
made available by folding of the v-SNARE and favorable
interactions with the t-SNARE (VAMP is in a random coil
before assembly and in an a helix within a helical bundle
after assembly; Fasshauer et al., 1997; Poirier et al., 1998;
Sutton et al., 1998). Or it could occur after assembly if the
SNAREpin is in a high energy state relative to bilayer lip-
ids that can be relieved due to a rearrangement of these
lipids. Current genetic, biochemical, and physiological re-
sults point to a loose state in which the SNAREs are par-
tially assembled in the membrane-distal portion, and a
tight state in which they are completely zipped-up (Han-
son et al., 1997a; Katz et al., 1998; Hua and Charlton, 1999;
Xu et al., 1999). It seems likely that the transition from the
loose to the tight state, which structurally would force at-
tached membranes into close proximity, may be when
most of the work on the bilayer is done to trigger fusion.
A priori, there are two general (and nonexclusive)
mechanisms by which bilayer lipids can be actively per-
turbed by assembled (or, assembling) pins: direct confor-
mational coupling, either via lipids associated with the an-
chor, linker, or surface of the rod of the pin; or pulling on
the membrane anchors due to force exerted from the rod
via taut linkers. Limits can now be placed on these mecha-
nisms in the case of SNARE-dependent fusion.
It appears that direct conformational coupling involving
the anchor, linker, and rod as a unit structure can be ruled
out, as can conformation-based coupling between the an-
chor or the linker and lipids. The fact that essentially free
torsional rotation can be introduced into the linker with-
out abolishing fusion (McNew et al., 1999) implies that
conformational coupling between rod and anchor is not
important. Therefore, a continuous region of secondary or
tertiary extending from rod through linker to anchor ei-
ther does not occur or is not important for fusion if it does.
Specific interactions between amino acid side chains of the
linker and phospholipids are unlikely to be important for
fusion because their nature and precise spacing from the
membrane can be altered without effect (McNew et al.,
1999). Finally, since we now know that C45 and C55 iso-
prenoid anchors unrelated in chemical structure to pep-
tidic anchors can support lipid mixing, potentially specific
interactions between peptidic anchors (v-v, v-t, or t-t) or
between their side chains and lipids are not important for
fusion.
The current evidence neither speaks for or against con-
formational coupling between the bilayer and the rod. For
example, the assembly of the rod at the interface between
the two bilayers could recruit certain species of lipids via
interactions between side chains protruding from the rod
and the lipid head groups, creating a local high-energy
state of the bilayer that contributes to the activation en-
ergy for fusion. However, the fact that fusion is dramati-
cally reduced as either the v- or t-SNARE linkers are sig-
nificantly extended (McNew et al., 1999) or abolished by
PE anchors, implies that if rod–bilayer coupling contrib-
utes to fusion, it is not sufficient for fusion.
This same observation (McNew et al., 1999) suggests
that force may be transduced, at least in part, by pulling on
the membrane anchors. The origin of the strain would lie
in the stability of the helical bundle of the rod, which
would generate a twisting force to do work on the bilayer
as the rod completes its assembly (loose to tight). This pro-
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the attached membranes that becomes prominent when
they are forced into intimate proximity as the SNAREs
zip-up their membrane proximal ends (Xu et al., 1999).
Extending the linker would gradually relieve this strain
and accordingly uncouple SNARE assembly from fusion.
Force Transduction by SNAREs during
Membrane Fusion
In sum, current evidence suggests that the helical bundle
of the SNARE complex in one or another way exerts force
on the membrane anchors, and that this provides an essen-
tial driving force for fusion. Other interactions, such as
possible linkage between the rod and the bilayer, may also
be important.
The pattern of activity of various lipid anchors is consis-
tent with this model and adds considerable detail. Presum-
ably, pulling on a membrane anchor serves to displace the
anchor from the bilayer, lifting out associated lipids to-
wards the contact point between the two bilayers, a pro-
cess which has been proposed to be an important trigger
for artificial bilayer fusion (Chernomordik and Zimmer-
berg, 1995; Chernomordik et al., 1995a,b, 1998, 1999). A
membrane anchor (whether peptidic or lipidic) that spans
both leaflets will perturb lipids on both sides of the mem-
brane as it is displaced; an anchor that samples only the
outer monolayer (corresponding to the cytoplasmic leaflet
in a cell) will perturb those lipids only in the outer mono-
layer. Our finding that C55 and C45 isoprenoid v-SNARE
anchors (which can in principle sample both monolayers)
promote fusion (measured by lipid mixing), but nei-
ther C20 nor C15 isoprenoids (which can only reside in
the outer monolayer) promote fusion, suggests that the
v-SNARE anchor needs to interact with both leaflets in
order to promote fusion as it is displaced toward the ap-
posing bilayer when pulled on by the attached linker.
An anchor of up to four phospholipids (involving up to
eight fatty acid chains) that is much more hydrophobic than
C55, but which is restricted to the outer monolayer, does
not permit the v-SNARE to fuse after docking, confirming
that bilayer topology, rather than hydrophobicity, is critical
for the function of the v-SNARE anchor unit. By contrast,
either multiple phospholipids or a single long chain (C45 or
C55) isoprenoid served as a functional t-SNARE anchor,
implying that overall hydrophobicity and not transmem-
brane topology is the critical feature of a t-SNARE an-
chor. The fusogenic activity of a t-SNARE anchor limited
to the outer monolayer implies that perturbation of these
lipids only is sufficient for fusion on the t-SNARE side.
The dynamic asymmetry implied by our results with
lipid anchors should not be surprising since the SNARE-
pin is not a symmetrical structure relative to the mem-
brane plane (Sutton et al., 1998). Asymmetric application
of force on the two sides of a fusion junction would explain
the asymmetric dimpling of membranes engaged in exocy-
tosis, observed by EM (Monck and Fernandez, 1992, 1994,
1996; Monck et al., 1995). It should also be noted that the
resistance of SNAREpins engaging in fusion to enzymatic
disruption by the ATPase NSF (Weber, T., F. Paralti, J.A.
McNew, R.J. Johnston, B. Westermann, T.H. Söllner, and
J.E. Rothman, manuscript submitted for publication) is
well-explained by the existence of forces during fusion
which would draw the bilayers together and effectively
seal them off from NSF or other extrinsic macromolecules.
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